Clinical potential of SKP2 as diagnostic marker and therapeutic target in small cell lung cancer.
BACKGROUND Small cell lung cancer (SCLC) is the most aggressive type of lung cancer. The overall survival has not improved significantly over the last decades because no major therapeutic breakthroughs have been achieved for over 15 years. METHODS We analyzed a genome-wide loss-of-function screening database to ident...